PA8768801A1 - Polimorfos de indol novedosos - Google Patents

Polimorfos de indol novedosos

Info

Publication number
PA8768801A1
PA8768801A1 PA20088768801A PA8768801A PA8768801A1 PA 8768801 A1 PA8768801 A1 PA 8768801A1 PA 20088768801 A PA20088768801 A PA 20088768801A PA 8768801 A PA8768801 A PA 8768801A PA 8768801 A1 PA8768801 A1 PA 8768801A1
Authority
PA
Panama
Prior art keywords
polymorphes
novedous
new indol
indol
new
Prior art date
Application number
PA20088768801A
Other languages
English (en)
Inventor
Tadayon Abdolsamad
Mannching Sherry Ku
Hsueh-Ling Wu
David Zenan Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8768801A1 publication Critical patent/PA8768801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

POLIMORFOS NOVEDOSOS, COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN POLIMORFOS NOVEDOSOS, MÉTODOS PARA UTILIZAR POLIMORFOS NOVEDOSOS Y MÉTODOS PARA PREPARAR POLIMORFOS NOVEDOSOS DE ÁCIDO [1-(4-TERC-BUTILBENCIL)-5-(3-METILFENIL) - 1H - INDOL - 3 - IL] (OXO) ACÉTICO DESCRIBEN AQUÍ.
PA20088768801A 2007-02-05 2008-02-01 Polimorfos de indol novedosos PA8768801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89947307P 2007-02-05 2007-02-05

Publications (1)

Publication Number Publication Date
PA8768801A1 true PA8768801A1 (es) 2009-02-09

Family

ID=39676711

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088768801A PA8768801A1 (es) 2007-02-05 2008-02-01 Polimorfos de indol novedosos

Country Status (8)

Country Link
US (1) US20080188542A1 (es)
EP (1) EP2061757A2 (es)
AR (1) AR065176A1 (es)
CL (1) CL2008000354A1 (es)
PA (1) PA8768801A1 (es)
PE (1) PE20081757A1 (es)
TW (1) TW200840564A (es)
WO (1) WO2008097938A2 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000253A1 (en) * 2001-06-20 2003-01-03 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)

Also Published As

Publication number Publication date
AR065176A1 (es) 2009-05-20
CL2008000354A1 (es) 2008-03-14
WO2008097938A2 (en) 2008-08-14
EP2061757A2 (en) 2009-05-27
PE20081757A1 (es) 2009-01-21
US20080188542A1 (en) 2008-08-07
TW200840564A (en) 2008-10-16
WO2008097938A3 (en) 2009-09-11

Similar Documents

Publication Publication Date Title
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
CR11427A (es) 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
UY32351A (es) Compuestos de pirimidinil indol para uso como inhibidores de atr
EA201170772A1 (ru) Органические соединения
DOP2011000176A (es) Compuestos organicos
CR9875A (es) Inhibidores de dipeptidilo peptidasa para tratar diabetes
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
EA200970156A1 (ru) Пиридизиноновые производные
BRPI0922364A2 (pt) Composto, composição farmacêutica e uso de um composto
EA201000149A1 (ru) Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз
GEP20156242B (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
EA201071224A1 (ru) Ингибиторы limk2, композиции, содержащие их, и способы их применения
UY32464A (es) Nuevos compuestos de indazol
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
NO20084007L (no) Spirokondenserte piperidiner som modulatorer av muskarinreseptorer
GT200800206A (es) Dimeros de derivados de artemisinina, su preparacion y su aplicacion en terapeutica
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CR11629A (es) INHIBIDORES HETEROCICLICOS DE ESTEAROIL-CoA- DESATURASA.
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
CO6341474A2 (es) Formas solidas de (1r,2s,3r)-1-(2-isoxazol-3-il)-1h-imidazol-4-il) butano-1,2,3,4-tetraol y metodos para su uso
CL2010001508A1 (es) Compuestos derivados de sulfanilmetil, sulfinilmetil y sulfonilmetil indol; composicion farmaceutica que los comprende; procedimiento de preparacion de dichos compuestos y uso para tratar y/o prevenir enfermedades cardiovasculares.